[The Fly] JPMorgan believes Pfizer Inc. (NYSE:PFE) is less likely to re-engage with AstraZeneca (AZN) after entering into an agreement to co-develop and co-commercialize MSB0010718C, Merck KGaA’s (MKGAY) anti-PDL1 antibody. The firm…